A growing number of surgical procedures requiring anesthesia, rising usage of inhalable anesthetics, and technological advancements about anesthesia delivery devices in the emerging markets, such as China and India are the major factors fueling the growth of the target market. According to the Centers of Disease Control and Prevention (CDC) in 2017, more than 51 million inpatient surgeries and 53 million outpatient surgeries were performed in the U.S. Increasing number of surgeries in Asia-Pacific (especially in China and India), mainly because of the high patient population levels is also boosting growth of the global market. Moreover, technological advancements in the anesthesia techniques and machines are also propelling the adoption rate of inhalation anesthetics. For instance, Sedana Medical advanced an anesthetic delivery system, AnaConDa, which allows the efficient and safe delivery of volatile anesthetics, such as sevoflurane or isoflurane, to the invasively ventilated patients.Inhalation Anesthetics Market accounted for US$ 1.5 billion in 2024 and is projected to register a moderate CAGR over the forecast period

The report "Global Inhalation Anesthetics Market, By Product (Desflurane, Sevoflurane, Isoflurane, and Other Products), By End User (Hospitals and Ambulatory Surgical Centers), By Application (Induction and Maintenance), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030.

Key Highlights:

• In January 2019, Sandoz has developed Desflurane in the U.S., Liquid for Inhalation, and the first generic of Suprane. The company is introducing Desflurane, USP, along with collaboration with Jiangsu Hengrui Medicine Co., the owner of the product’s Abbreviated New Drug Application (ANDA).
• In July 2019, AbbVie Inc. declared that it has acquired Seattle-based Mavupharma, a privately held biopharmaceutical company. The company focused on novel approaches to target the STING (STimulator of Interferon Genes) pathway for the treatment of cancer

Key Market Insights from the report:        

The global inhalation anesthetics market accounted for US$ 1.5 billion in 2024 and is projected to register a moderate CAGR over the forecast period. The market report has been segmented based on product, end-user, application, and region.

• By product, sevoflurane is widely used for anesthesia induction due to its low cost and therapeutic advantages.
• By end-user, the global market is segmented into hospitals and ambulatory surgical centres
• By application, in 2018, the maintenance segment dominated the target market with the highest revenue share and is expected to grow at a significant CAGR over the forecast period. This is mainly attributed due to the higher requirement of volume for maintenance and faster induction and recovery from anesthesia
• By region, in 2018, North America led the target market and is projected to grow at a profitable rate during the forecast period, due to growing prevalence of various chronic diseases and availability of advanced healthcare facilities. Also, the demand for surgical products which includes ambulatory surgery and inpatient surgery is the highest in North America and is a major growth booster for the regional market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Inhalation Anesthetics Market”, By Product (Desflurane, Sevoflurane, Isoflurane, and Other Products), By End User (Hospitals and Ambulatory Surgical Centers), By Application (Induction and Maintenance), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

The prominent player operating in the global Inhalation Anesthetics market includes AbbVie Inc., Novartis AG (Sandoz), Fresenius SE & Co. KGaA, Baxter International Inc., Halocarbon Products Corporation, Lunan Pharmaceuticals Group, Hikma Pharmaceuticals PLC, Jiangsu Hengrui Medicine Co. Ltd., Piramal Group, and Troikaa Pharmaceuticals Ltd.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

 U.S.  1 860 531 2574

RoW: 917775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com